Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Nephrology

Building Your Care Team and Staying Proactive

At a Glance

HNF1B-related kidney disease is a multisystem condition, so care should be coordinated across the lifespan. A personalized plan tracks kidney function, electrolytes, blood sugar, liver and pancreatic health, reproductive health, and development, with extra support when a 17q12 deletion is present.

Because HNF1B-related disease can affect so many different parts of the body, managing it is not a “one-doctor job.” Instead, care is most effective when it is structured as a proactive partnership between you and a team of specialists. This team works together to monitor your health over time, aiming to catch and manage any new symptoms early [1][2].

Your Multidisciplinary Team

Think of your care team as a circle of experts, with you (or your child) at the center. Depending on your specific genetic result and symptoms, your team may include:

  • Nephrologist (Kidney Specialist): The “anchor” for most patients. They monitor kidney function and balance electrolytes like magnesium [3].
  • Endocrinologist (Hormone/Diabetes Specialist): Essential for monitoring blood sugar and managing MODY5 diabetes [4].
  • Geneticist/Genetic Counselor: Helps you understand your specific genetic report, discusses family planning, and coordinates testing for other family members [5].
  • Gastroenterologist (GI Specialist): Involved if there are liver enzyme changes or signs of pancreatic exocrine insufficiency (like weight loss or oily stools) [6].
  • Gynecologist or Urologist: Monitors for reproductive tract differences, providing fertility or symptom management [7].
  • Neurodevelopmental Specialists: For those with a 17q12 deletion, this may include developmental pediatricians, psychologists, or school support teams to help with learning and behavior [8][1].

A Roadmap for Monitoring

While every patient is different, experts recommend a regular “surveillance schedule” to stay ahead of the condition. There is no single surveillance schedule that fits a child with normal kidney function, an adult with advanced CKD, and someone taking multiple medications. The frequency of tests depends entirely on your age, symptoms, current eGFR, and treatments. You can use the following as a starting framework to individualize with your doctor [3][9]:

System Recommended Framework (Individualize with your doctor) What They Are Looking For
Kidneys & Electrolytes Blood Pressure, eGFR, Urine Albumin/Protein, Magnesium, Potassium Changes in filtration, protein spillage, or electrolyte wasting. Frequency depends on age, CKD stage, and medications.
Diabetes HbA1c or Glucose testing (at least annually; more frequent if diabetes is present) The onset of MODY5 or blood sugar fluctuations [4].
Liver/GI Liver Enzymes; Fecal Elastase only if experiencing weight loss or GI symptoms Liver health and the need for digestive enzymes [6][10].
Imaging Kidney Ultrasound (interval determined by nephrologist) Changes in kidney structure or cysts [11].
Gout/Uric Acid Uric Acid levels Checked based on your history of gout or kidney stones.
Development Periodic screenings (especially for 17q12 deletions) Support for learning, language, or social communication [12].

Note: Routine repeat ultrasounds, MRCPs, or reproductive imaging are not required for every person; they are guided by symptoms and clinical need.

Proactive Surveillance Across the Lifespan

Monitoring needs often change as you grow. For example, electrolyte issues like low magnesium may not appear until later childhood, so “normal” labs when a child is very young do not mean they won’t need monitoring later [13]. Similarly, screening for reproductive anatomy (like MRKH syndrome) is individualized according to anatomy, puberty/menstrual history, and specialist advice [7][1].

Transition of Care: Moving from pediatric to adult care is a major milestone. Work with your pediatric nephrologist and endocrinologist early (often in the mid-teen years) to build a transition plan so that medical history is seamlessly transferred to adult providers.

For those with a 17q12 deletion, longitudinal follow-up should also track cognitive development, motor coordination, and behavioral health [14]. This “whole-person” approach ensures that even if you are currently asymptomatic, your team is ready to provide support the moment it is needed. Remember, the goal of this monitoring is not to find problems, but to empower you with the information needed to live a healthy, active life [1].

Common questions in this guide

Which specialists usually care for someone with HNF1B-related kidney disease?
A nephrologist usually anchors the team and monitors kidney function and electrolytes. An endocrinologist and genetics professional are often involved, while gastroenterology, gynecology or urology, and developmental specialists are added when symptoms, a 17q12 deletion, or life stage make them relevant. The exact team is individualized.
What should be checked regularly in HNF1B-related kidney disease?
Monitoring may include blood pressure, kidney filtration (eGFR), urine protein or albumin, magnesium, potassium, and glucose or HbA1c. Liver enzymes, stool testing for pancreatic function, kidney ultrasound, uric acid, and developmental screening are added based on symptoms, age, kidney stage, and treatment. There is no single schedule that fits everyone.
Can a child with normal early kidney tests stop being monitored?
No. Electrolyte problems such as low magnesium may appear later in childhood, so normal results in a very young child do not rule out future changes. The monitoring schedule should be adjusted over time with the child’s care team.
Why is developmental follow-up important with a 17q12 deletion?
A 17q12 deletion can be associated with differences in learning, language, motor coordination, behavior, or social communication. Regular developmental and behavioral screening helps identify support needs early, including school or psychological services.
When should children with HNF1B-related disease transition to adult care?
Transition planning should begin before adulthood, often in the mid-teen years, with the pediatric nephrologist, endocrinologist, and family. A written plan should transfer the medical history, test results, medicines, and care responsibilities to adult providers so follow-up remains coordinated.
Are kidney ultrasounds, MRCPs, or reproductive imaging needed routinely?
Not for everyone. Repeat ultrasounds, MRCPs, or reproductive imaging are generally guided by symptoms, anatomy, puberty or menstrual history, and specialist advice. Your doctors can explain which imaging is clinically useful and when it should be repeated.

Get notified when new evidence is published on HNF1B-related autosomal dominant tubulointerstitial kidney disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    17q12 Deletion Syndrome as a Rare Cause for Diabetes Mellitus Type MODY5.

    Roehlen N, Hilger H, Stock F, et al.

    The Journal of clinical endocrinology and metabolism 2018; (103(10)):3601-3610 doi:10.1210/jc.2018-00955.

    PMID: 30032214
  2. 2

    17q12 Recurrent Deletion Syndrome in Childhood.

    Ceravolo G, Mollica S, Cavallaro M, et al.

    Genes 2025; (16(12)) doi:10.3390/genes16121499.

    PMID: 41465172
  3. 3

    Fifteen minute consultation: managing children with HNF1B pathogenic variants.

    O'Gorman JR, Tse Y, Reid J, et al.

    Archives of disease in childhood. Education and practice edition 2026; doi:10.1136/archdischild-2026-330293.

    PMID: 42601188
  4. 4

    Diabetes, Associated Clinical Spectrum, Long-term Prognosis, and Genotype/Phenotype Correlations in 201 Adult Patients With Hepatocyte Nuclear Factor 1B (HNF1B) Molecular Defects.

    Dubois-Laforgue D, Cornu E, Saint-Martin C, et al.

    Diabetes care 2017; (40(11)):1436-1443 doi:10.2337/dc16-2462.

    PMID: 28420700
  5. 5

    Prenatal diagnosis and family analysis of 17q12 microdeletion syndrome with fetal renal abnormalities.

    Zhang F, Gu Q, Song J, et al.

    Frontiers in genetics 2024; (15()):1401315 doi:10.3389/fgene.2024.1401315.

    PMID: 38957807
  6. 6

    Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic.

    Clissold RL, Fulford J, Hudson M, et al.

    Clinical kidney journal 2018; (11(4)):453-458 doi:10.1093/ckj/sfx150.

    PMID: 30094008
  7. 7

    A Case of Chromosome 17q12 Deletion Syndrome with Type 2 Mayer-Rokitansky-Küster-Hauser Syndrome and Maturity-Onset Diabetes of the Young Type 5.

    Lee R, Choi JE, Mun E, et al.

    Children (Basel, Switzerland) 2024; (11(4)) doi:10.3390/children11040404.

    PMID: 38671621
  8. 8

    Review of neurodevelopmental disorders in patients with HNF1B gene variations.

    Nittel CM, Dobelke F, König J, et al.

    Frontiers in pediatrics 2023; (11()):1149875 doi:10.3389/fped.2023.1149875.

    PMID: 36969268
  9. 9

    Genotype-phenotype correlations and response to glucose lowering therapy in subjects with HNF1β associated diabetes.

    Ng N, Mijares Zamuner M, Siddique N, et al.

    Acta diabetologica 2022; (59(1)):83-93 doi:10.1007/s00592-021-01794-8.

    PMID: 34487217
  10. 10

    The Landscape of HNF1B Deficiency: A Syndrome Not Yet Fully Explored.

    Gambella A, Kalantari S, Cadamuro M, et al.

    Cells 2023; (12(2)) doi:10.3390/cells12020307.

    PMID: 36672242
  11. 11

    Clinical Spectrum and Early Renal Functional Variability in a Nationwide Greek Pediatric HNF1B Multicenter Cohort.

    Dotis J, Zampetoglou A, Askiti V, et al.

    Journal of clinical medicine 2026; (15(17)) doi:10.3390/jcm15176590.

    PMID: 42739594
  12. 12

    17q12 deletion and duplication syndrome in Denmark-A clinical cohort of 38 patients and review of the literature.

    Rasmussen M, Vestergaard EM, Graakjaer J, et al.

    American journal of medical genetics. Part A 2016; (170(11)):2934-2942 doi:10.1002/ajmg.a.37848.

    PMID: 27409573
  13. 13

    HNF1B Mutations Are Associated With a Gitelman-like Tubulopathy That Develops During Childhood.

    Adalat S, Hayes WN, Bryant WA, et al.

    Kidney international reports 2019; (4(9)):1304-1311 doi:10.1016/j.ekir.2019.05.019.

    PMID: 31517149
  14. 14

    Improving renal phenotype and evolving extra-renal features of 17q12 deletion encompassing the HNF1B gene.

    Cleper R, Reches A, Shapira D, et al.

    Translational pediatrics 2021; (10(12)):3130-3139 doi:10.21037/tp-21-386.

    PMID: 35070826

This page provides general information about coordinating care and monitoring for HNF1B-related kidney disease; it is for educational purposes only and does not constitute medical advice. Your nephrologist and other specialists should personalize the schedule for you or your child.